Screenshot In a recent New York Times article, Gina Kolata explores a striking trend in modern medicine: physicians, particularly in cardiology and endocrinology, are increasingly turning to GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound—not just for their patients, but for themselves. The piece highlights how these medications, initially designed to manage diabetes, are now being embraced by medical professionals... Continue Reading →
From the New York Times: The Diabetic foot and amputations as a measure of our nation’s health system #ActAgainstAmputation #ALPSlimb #NYT
A tour de force by the NYT's Nick Kristof One of the solutions? Expansion of medicare/medicaid services. This fits so very well with work from our collective team. When foot care was removed during the economic crisis of 2008, diabetic amputation, sepsis and death increased. When foot care was expanded in Affordable Care Act early... Continue Reading →